-2.50%
14.46%
63.67%
68.25%
117.33%
-25.45%
-49.15%

Company Description

Warby Parker Inc.provides eyewear products.It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray.


The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps.As of May 16, 2022, it had 160 retail stores in the United States and Canada.The company was formerly known as JAND, Inc.


and changed its name to Warby Parker Inc.in June 2021.Warby Parker Inc.


was incorporated in 2009 and is headquartered in New York, New York.

Market Data

Last Price 27.71
Change Percentage -2.50%
Open 28.4
Previous Close 28.42
Market Cap ( Millions) 3335
Volume 1232283
Year High 28.68
Year Low 11.35
M A 50 24.43
M A 200 17.74

Financial Ratios

FCF Yield 0.98%
Dividend Yield 0.00%
ROE -10.14%
Debt / Equity 58.25%
Net Debt / EBIDTA 705.69%
Price To Book 9.95
Price Earnings Ratio -102.88
Price To FCF 102.25
Price To sales 4.49
EV / EBITDA -421.88

News

Business Breakdown

Expected Mid-Term Growth

Segment nΒ°1 -> Eyewear Products

Expected Growth : 15.4 %

What the company do ?

Warby Parker Inc. offers a wide range of stylish and affordable eyewear products, including prescription glasses, sunglasses, and contact lenses for men, women, and kids.

Why we expect these perspectives ?

Increasing demand for stylish and affordable eyewear, growing online presence, and expansion into new markets drive Warby Parker's growth. The company's innovative try-before-you-buy model and home try-on program also contribute to its success.

Segment nΒ°2 -> Services and Other

Expected Growth : 15.4 %

What the company do ?

Warby Parker's Services include eye exams and online WarbyParker.com sales, while Other includes non-prescription sunglasses and accessories.

Why we expect these perspectives ?

Warby Parker's services, including eye exams and online sales, are expected to drive growth, fueled by increasing demand for convenient and affordable eye care. The non-prescription sunglasses and accessories segment will also contribute to growth, driven by the rising popularity of fashion eyewear.

Warby Parker Inc. Products

Product Range What is it ?
Eyeglasses Warby Parker offers a wide range of stylish and affordable eyeglasses for men and women, including single vision, progressive, and reading glasses.
Sunglasses Warby Parker's sunglasses collection features trendy and functional designs for men and women, with polarized and non-polarized lens options.
Contact Lenses Warby Parker offers a convenient and affordable contact lens subscription service, with a wide range of lens types and brands available.
Eye Exams Warby Parker offers comprehensive eye exams at their retail locations, performed by licensed optometrists.
Insurance Services Warby Parker accepts many major insurance providers and offers in-network benefits for eye exams and eyewear purchases.

Warby Parker Inc.'s Porter Forces

Warby Parker's products are moderately substitutable with other eyewear brands, but the company's unique business model and brand identity help to differentiate it from competitors.

Warby Parker's customers have some bargaining power due to the availability of alternative eyewear brands, but the company's affordable prices and convenient home try-on program help to mitigate this power.

Warby Parker's suppliers have limited bargaining power due to the company's large scale of operations and ability to negotiate favorable prices.

The eyewear industry has moderate barriers to entry, and new entrants may face challenges in replicating Warby Parker's business model and brand recognition, but the company still needs to be vigilant in responding to potential new competitors.

The eyewear industry is highly competitive, with many established brands and new entrants vying for market share, and Warby Parker must continue to innovate and differentiate itself to maintain its market position.

Capital Structure

Value
Debt Weight 36.63%
Debt Cost 3.95%
Equity Weight 63.37%
Equity Cost 12.14%
WACC 9.14%
Leverage 57.81%

Historical Valuation

Price/Earnings Ratio

Margin Valuation

Peers Valuation

Competitors

Company Rational
SMTI Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen …
LMAT LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing …
RVP Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and …
ATRC AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. …
DXR Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to …

Peers Metrics

DCF BETA

Parameters

Short Term Growth
Short term Time
Long-Term Growth
WACC
Target Price
27.71$
Current Price
27.71$
Potential
-0.00%

Expected Cash-Flows

Scoring Insights

Peers Group Analysis

πŸ₯‡

LeMaitre Vascular Logo
LeMaitre Vascular
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

πŸ₯ˆ

Daxor Logo
Daxor
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

πŸ₯‰

Retractable Technologies Logo
Retractable Technologies
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

4

Warby Parker Logo
Warby Parker
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

5

Sanara MedTech Logo
Sanara MedTech
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

6

AtriCure Logo
AtriCure
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->